This inventor holds 4 USPTO granted patents. Top assignees: Ono Pharmaceutical Co., Ltd., Ono Pharmaceuticals Co., Ltd.. Active years: 2000-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2000 - 2002)
- Mishima-gun, JP (2004)
Company Filing History:
Years Active: 2000-2004
Title: Katsuhito Sakaki: Innovator in Pharmaceutical Chemistry
Introduction
Katsuhito Sakaki is a notable inventor based in Mishima-gun, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hydroxamic acid derivatives and sulfonylamino acid derivatives. With a total of 4 patents to his name, Sakaki has established himself as a key figure in the development of new therapeutic agents.
Latest Patents
Sakaki's latest patents include groundbreaking research on hydroxamic acid derivatives, which outlines a process for their production and the formulation of drugs containing these compounds as active ingredients. Additionally, he has developed methods for treating diseases using sulfonylamino acid derivatives, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Sakaki has worked with prominent companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His work in these organizations has allowed him to contribute to the development of innovative treatments that address various health challenges.
Collaborations
Sakaki has collaborated with esteemed colleagues such as Hidekazu Kanazawa and Tsuneyuki Sugiura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in pharmaceutical chemistry.
Conclusion
Katsuhito Sakaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for new treatments and innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile